Gabelli Funds’s Achillion Pharmaceuticals ACHN Stock Holding History

Gabelli Funds’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-369,073	Closed	-$2.23M	–	1148
2019 Q4	$2.23M	Buy	+369,073	New	+$2.14M	0.01%	703

Gabelli Funds's ACHN Position: Q1 2020 in Review

Gabelli Funds sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 369,073 shares — an estimated $2.23M sold.

Gabelli Funds first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $2.23M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Gabelli Funds reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Gabelli Funds sold 369,073 Achillion Pharmaceuticals shares in Q1 2020, an estimated $2.23M.
Gabelli Funds first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Gabelli Funds's Achillion Pharmaceuticals position peaked at $2.23M in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Gabelli Funds's 13F filing for Q1 2020, filed 14 May 2020.